Haemostatic reference intervals in pregnancy

 

 Buy Article Permissions and Reprints

Summary

Haemostatic reference intervals are generally based on samples from non-pregnant women. Thus, they may not be relevant to pregnant women, a problem that may hinder accurate diagnosis and treatment of haemostatic disorders during pregnancy. In this study, we establish gestational age-specific reference intervals for coagulation tests during normal pregnancy. Eight hundred one women with expected normal pregnancies were included in the study. Of these women, 391 had no complications during pregnancy, vaginal delivery, or postpartum period. Plasma samples were obtained at gestational weeks 13–20, 21–28, 29–34, 35–42, at active labor, and on postpartum days 1 and 2. Reference intervals for each gestational period using only the uncomplicated pregnancies were calculated in all 391 women for activated partial thromboplastin time (aPTT), fibrinogen, fibrin D-dimer, antithrombin, free protein S, and protein C and in a subgroup of 186 women in addition for prothrombin time (PT), Owren and Quick PT, protein S activity, and total protein S and coagulation factors II, V, VII, VIII, IX, X, XI, and XII. The level of coagulation factors II, V, X, XI, XII and antithrombin, protein C, aPTT, PT remained largely unchanged during pregnancy, delivery, and postpartum and were within non-pregnant reference intervals. However, levels of fibrinogen, D-dimer, and coagulation factors VII, VIII, and IX increased markedly. Protein S activity decreased substantially, while free protein S decreased slightly and total protein S was stable. Gestational age-specific reference values are essential for the accurate interpretation of a subset of haemostatic tests during pregnancy, delivery, and puerperium.

• References

• 1 Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29: 125-130.
  Article in Thieme ConnectPubMedGoogle Scholar
• 2 Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114: 409-414.
  CrossrefPubMedGoogle Scholar
• 3 O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003; 17: 385-396.
  CrossrefPubMedGoogle Scholar
• 4 Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006; 95: 401-413.
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009; 114: 1326-1331.
  CrossrefPubMedGoogle Scholar
• 6 Handbook of clinical laboratory testing during pregnancy. Gronowski A (ed) Totowa: Humana Press; 2004
  Google Scholar
• 7 Horowitz GL, Altaie S, Boyd JC. et al. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, C28A3E. Third Ed. Wayne: Clinical and Laboratory Standards Institute; 2008
  Google Scholar
• 8 Klajnbard A, Szecsi PB, Colov NP. et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med 2010; 48: 237-248.
  CrossrefPubMedGoogle Scholar
• 9 Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004; 42: 710-714.
  PubMedGoogle Scholar
• 10 Bellart J, Gilabert R, Miralles RM. et al. Endothelial cell markers and fibrinopep-tide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998; 46: 17-21.
  CrossrefPubMedGoogle Scholar
• 11 Faught W, Garner P, Jones G. et al. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995; 172: 147-150.
  CrossrefPubMedGoogle Scholar
• 12 Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol 2002; 81: 611-615.
  CrossrefPubMedGoogle Scholar
• 13 Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 119: 185-188.
  CrossrefPubMedGoogle Scholar
• 14 Persson KE, Hillarp A, Dahlback B. Analytical considerations for free protein S as-says in protein S deficiency. Thromb Haemost 2001; 86: 1144-1147.
  Article in Thieme ConnectPubMedGoogle Scholar
• 15 Lijfering WM, Mulder R, Ten Kate MK. et al. Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives. Blood 2009; 113: 1225-1230.
  CrossrefPubMedGoogle Scholar
• 16 Clark P, Brennand J, Conkie JA. et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Stirling Y, Woolf L, North WR. et al. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-182.
  Article in Thieme ConnectPubMedGoogle Scholar
• 18 Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12: 141-154.
  CrossrefPubMedGoogle Scholar
• 19 Muller-Berghaus G, Moeller RM, Mahn I. Fibrinogen turnover in pregnant rabbits during the first and last thirds of gestation. Am J Obstet Gynecol 1978; 131: 655-660.
  CrossrefPubMedGoogle Scholar
• 20 Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem 2005; 51: 825-829.
  CrossrefPubMedGoogle Scholar
• 21 Chan WS, Chunilal S, Lee A. et al. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med 2007; 147: 165-170.
  CrossrefPubMedGoogle Scholar
• 22 Eichinger S. Diagnostic issues of VTE in pregnancy. Thromb Res 2009; 123 (Suppl. 02) S38-S40.
  CrossrefPubMedGoogle Scholar
• 23 Chunilal SD, Bates SM. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb Haemost 2009; 101: 428-438.
  Article in Thieme ConnectPubMedGoogle Scholar